Rays of Belief

Founded in 2017, Rays of Belief has evolved into a specialized social enterprise dedicated to supporting children with Neurodevelopmental Disorders (NDDs). The company focuses on children between 18 months and 12 years, while extending vocational and life skills training for children up to 15 years to foster independence.

Its core business model revolves around a holistic intervention approach. This includes early intervention, language therapy, occupational therapy, parental guidance, and family support programs. By combining clinical expertise with tailored resources, the company aims to improve the quality of life for children with ASD, ADHD, Cerebral Palsy, and Intellectual Disabilities.

The company's operational scale is supported by a robust infrastructure featuring over 150 teaching tools at its centers and 2,000+ tools designed for home learning. It leverages a network of more than 340 clinical professionals to maintain the quality and efficacy of its intervention programs.

Geographically, the company is expanding its footprint, as evidenced by the establishment of subsidiaries such as Moms Belief US Inc. to manage lease and license payments for existing centers in the USA, indicating an ambition to scale its specialized healthcare model globally.

The enterprise is led by promoters Nitin Bindlish and Carving Futures Pte. Ltd., who have steered the organization from a specialized startup into a scalable healthcare provider for neurodevelopmental needs.

Rays of Belief is launching a mainboard IPO to raise approximately ₹125 Crores, consisting entirely of a fresh issue with no Offer for Sale (OFS). The price band is set between ₹227 and ₹239 per share, with a minimum retail lot size of 62 shares requiring an application amount of ₹14,818. The issue is scheduled to open on September 1, 2026, and close on September 3, 2026, with listing on the BSE and NSE on September 8, 2026.

The proceeds from the fresh issue are earmarked for significant growth initiatives. Key allocations include ₹26.88 Crores for Company Learning Centres, ₹14.45 Crores for lease payments of existing Indian centers, and ₹10.13 Crores for the US subsidiary, Moms Belief US Inc. Additional funds are allocated to school collaboration centers, brand awareness, and a Centre for Excellence and Research.

Financial performance shows a massive jump in top-line growth, with revenue increasing from ₹30.76 Crores in FY24 to ₹82.06 Crores in FY26. However, profitability has been inconsistent; the PAT grew from ₹0.85 Crores in FY24 to ₹5.88 Crores in FY25, but subsequently dipped to ₹4.96 Crores in FY26 despite the revenue surge, indicating pressure on margins.

From a valuation perspective, the company reports a strong Return on Equity (ROE) of 21.64% and a basic EPS of ₹3.21. A significant point of interest is the lack of listed peers in India, making relative valuation difficult and leaving the company to set its own pricing benchmark.

Investment strengths include the 100% fresh issue structure, which ensures capital remains within the company, and the high ROE. Conversely, the primary risks include the declining PAT trend in the most recent year and the lack of comparable listed peers to validate the valuation.

Investors should view this as a growth-oriented play in a niche social-healthcare segment. While the financial growth in revenue is impressive, the sustainability of profits during rapid expansion will be the key metric to watch post-listing.